Sang-Wook Yoon - Search Results

Year	Number of Results
2002	5
2003	1
2004	2
2005	2
2006	1
2007	1
2008	2
2010	3
2011	5
2012	3
2013	1
2014	2
2015	3
2016	3
2017	6
2019	1
2020	1
2021	1
2022	4

1

An update on the adalimumab biosimilar landscape following the approval of the first high-concentration biosimilar.

Fusaro E, Durez P, Wohlrab J, Lee S, SangWook Yoon, Marotte H. Fusaro E, et al. Immunotherapy. 2021 Dec 6. doi: 10.2217/imt-2021-0271. Online ahead of print. Immunotherapy. 2021. PMID: 34865524

2

An introduction to biosimilar cancer therapeutics: definitions, rationale for development and regulatory requirements.

Buske C, Ogura M, Kwon HC, Yoon SW. Buske C, et al. Among authors: yoon sw. Future Oncol. 2017 May;13(15s):5-16. doi: 10.2217/fon-2017-0153. Future Oncol. 2017. PMID: 28482702 Free article. Review.

3

Scientific rationale for extrapolation of biosimilar data across cancer indications: case study of CT-P10.

Ogura M, Coiffier B, Kwon HC, Yoon SW. Ogura M, et al. Among authors: yoon sw. Future Oncol. 2017 May;13(15s):45-53. doi: 10.2217/fon-2017-0156. Future Oncol. 2017. PMID: 28482699 Free article. Review.

4

Development of CT Effective Dose Conversion Factors from Clinical CT Examinations in the Republic of Korea.

Lee SK, Kim JS, Yoon SW, Kim JM. Lee SK, et al. Among authors: yoon sw. Diagnostics (Basel). 2020 Sep 21;10(9):727. doi: 10.3390/diagnostics10090727. Diagnostics (Basel). 2020. PMID: 32967352 Free PMC article.

5

Stepping Forward to the Next Level: Totality of Evidence for the First High-Concentration Adalimumab Biosimilar, CT-P17.

Viapiana O, Lee S, Yoon S, Fautrel B. Viapiana O, et al. Clin Drug Investig. 2022 Feb;42(2):103-112. doi: 10.1007/s40261-021-01107-5. Epub 2022 Jan 13. Clin Drug Investig. 2022. PMID: 35025072 Review.

6

NATIONAL DIAGNOSTIC REFERENCE LEVELS AND ACHIEVABLE DOSES FOR 13 ADULT CT PROTOCOLS AND A PAEDIATRIC HEAD CT PROTOCOL: NATIONAL SURVEY OF KOREAN HOSPITALS.

Kim JS, Lee SK, Kim SK, Yoo SM, Kim JM, Yoon SW. Kim JS, et al. Among authors: yoon sw. Radiat Prot Dosimetry. 2019 Dec 31;187(2):220-229. doi: 10.1093/rpd/ncz156. Radiat Prot Dosimetry. 2019. PMID: 31322696

7

Meiotic prophase roles of Rec8 in crossover recombination and chromosome structure.

Yoon SW, Lee MS, Xaver M, Zhang L, Hong SG, Kong YJ, Cho HR, Kleckner N, Kim KP. Yoon SW, et al. Nucleic Acids Res. 2016 Nov 2;44(19):9296-9314. doi: 10.1093/nar/gkw682. Epub 2016 Aug 2. Nucleic Acids Res. 2016. PMID: 27484478 Free PMC article.

8

Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit.

Alten R, An Y, Kim DH, Yoon S, Peyrin-Biroulet L. Alten R, et al. Clin Drug Investig. 2022 Jun;42(6):477-489. doi: 10.1007/s40261-022-01162-6. Epub 2022 Jun 3. Clin Drug Investig. 2022. PMID: 35657560 Review.

9

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era.

Schreiber S, Ben-Horin S, Alten R, Westhovens R, Peyrin-Biroulet L, Danese S, Hibi T, Takeuchi K, Magro F, An Y, Kim DH, Yoon S, Reinisch W. Schreiber S, et al. Adv Ther. 2022 Jun;39(6):2342-2364. doi: 10.1007/s12325-021-01990-6. Epub 2022 Jan 6. Adv Ther. 2022. PMID: 34988877 Free PMC article. Review.

10

Mitotic cohesin subunit Mcd1 regulates the progression of meiotic recombination in budding yeast.

Lee MS, Yoon SW, Kim KP. Lee MS, et al. Among authors: yoon sw. J Microbiol Biotechnol. 2015 May;25(5):598-605. doi: 10.4014/jmb.1501.01081. J Microbiol Biotechnol. 2015. PMID: 25737120 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results